These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25355804)

  • 1. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
    Kobayashi Y; Yoshida S; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 Apr; 99(4):451-6. PubMed ID: 25281471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
    El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
    Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy.
    Yoshida S; Ishikawa K; Asato R; Arima M; Sassa Y; Yoshida A; Yoshikawa H; Narukawa K; Obika S; Ono J; Ohta S; Izuhara K; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5670-8. PubMed ID: 21508107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
    Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
    Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
    Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between vitreous cytokine levels and inflammatory cells in fibrovascular membranes of patients with proliferative diabetic retinopathy.
    Urbančič M; Petrovič D; Živin AM; Korošec P; Fležar M; Petrovič MG
    Mol Vis; 2020; 26():472-482. PubMed ID: 32606566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin in vitreoretinal diseases.
    Yoshida S; Nakama T; Ishikawa K; Nakao S; Sonoda KH; Ishibashi T
    Cell Mol Life Sci; 2017 Dec; 74(23):4329-4337. PubMed ID: 28913545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of elevated intravitreal IL-1β and IL-10 levels in proliferative diabetic retinopathy.
    Mao C; Yan H
    Indian J Ophthalmol; 2014 Jun; 62(6):699-701. PubMed ID: 25005199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
    Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
    Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
    Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
    Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
    Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.
    Zhang X; Yu W; Dong F
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):661-8. PubMed ID: 22160564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
    Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
    Front Immunol; 2020; 11():613975. PubMed ID: 33679701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.